|
SNRNP27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.77076189453874E-15 |
| Normal-vs-Stage2 |
1.35670030765311E-10 |
| Normal-vs-Stage3 |
1.70974345792274E-14 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.532400E-01 |
| Stage1-vs-Stage3 |
5.243700E-02 |
| Stage1-vs-Stage4 |
1.420880E-03 |
| Stage2-vs-Stage3 |
6.534200E-01 |
| Stage2-vs-Stage4 |
7.925600E-02 |
| Stage3-vs-Stage4 |
1.105360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.82915999999977E-05 |
| Normal-vs-Asian |
2.80629963711476E-10 |
| Caucasian-vs-AfricanAmerican |
1.325030E-01 |
| Caucasian-vs-Asian |
8.206400E-01 |
| AfricanAmerican-vs-Asian |
2.688600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
8.706300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35544916904473E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63624669369256E-12 |
| Normal-vs-Age(81-100Yrs) |
4.16570000000283E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.798300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.332450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.479000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.922600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.840000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.750600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.639600E-01 |
| Classical-VS-Follicular |
2.315900E-02 |
| Classical-VS-Other |
5.920000E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
1.754040E-02 |
| Tall-VS-Other |
3.420400E-01 |
| Tall-VS-Normal |
3.56670248891078E-11 |
| Follicular-VS-Other |
7.576000E-01 |
| Follicular-VS-Normal |
8.70409999631505E-08 |
| Other-VS-Normal |
2.202900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.99680288865056E-15 |
| Normal-vs-N1 |
6.50539622171209E-11 |
| N0-vs-N1 |
5.259200E-01 |
|
|
